Kristin Kohler, PA
Medical · Baltimore, MDNPI 1366765679
Payments from drug & device makers
Across 81 payments — averaging $24.47 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- AbbVie$439
- Johnson & Johnson$257
- Eisai Inc.$240
- Merck$122
- Regeneron Healthcare Solutions, Inc.$108
- Novartis$102
- plus $713 from 18 others
What the payments were for
- Food & beverage$1,982100%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| AbbVie | 18 | $439 |
| Johnson & Johnson(2 entities) | 9 | $257 |
| Eisai Inc. | 11 | $240 |
| Merck | 6 | $122 |
| Regeneron Healthcare Solutions, Inc. | 5 | $108 |
| Novartis | 6 | $102 |
| AstraZeneca | 3 | $94 |
| Pfizer | 1 | $71 |
| Baxter Healthcare | 2 | $71 |
| Nestle Healthcare Nutrition Inc. | 3 | $67 |
| Bayer | 2 | $59 |
| Medtronic | 3 | $53 |
| Integra Lifesciences Corporation | 1 | $34 |
| Novocure Inc. | 1 | $33 |
| Beone Medicines USA, Inc. | 1 | $29 |
| Kerecis Limited | 1 | $29 |
| Tempus AI, Inc | 1 | $28 |
| Pharmacosmos Therapeutics Inc. | 1 | $26 |
| Springworks Therapeutics, Inc. | 1 | $25 |
| Angiodynamics, Inc. | 1 | $23 |
| Incyte Corporation | 1 | $20 |
| Alnylam Pharmaceuticals Inc. | 1 | $19 |
| Digestive Care, Inc. | 1 | $18 |
| Hologic Sales And Service, LLC | 1 | $14 |
How this compares
$1,982 in reported general payments places this provider in the 70th percentile of 543 medical providers in Maryland.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Lactated RingersRinger's Solution,lactated | 20 | $355 |
| Ondansetron OdtOndansetron | 20 | $153 |
| Pantoprazole Sodium | 19 | $138 |
| Oxycodone Hcl | 20 | $107 |
| Tramadol Hcl | 12 | $36 |
Paid to pharmacies, not to this prescriber.
Other medical in Baltimore
- Sarah SagorskyBaltimore$68K
- Maribeth HatalskiBaltimore$11K
- Edward MikulaBaltimore$11K
- Natalie OrbachBaltimore$10K
- Helen ReidlerBaltimore$10K
- Michelle DanielsBaltimore$9K
- Chana AbramsBaltimore$7K
- Joshua PertmanBaltimore$7K
- Victoria TrottStevensville$94K
- Emily GrisnikLeonardtown$62K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.